By Meryl Nass, MD | April 30, 2022 Remdesivir is an IV drug. Therefore, for the past 2 years it was almost exclusively used in hospitalized patients, not outpatients. Royalties go to Gilead, but a portion go the the NIAID, Tony Fauci’s agency and to the US Army, which assisted with its development. Remdesivir received […]
Source